US 10919891
Heterocyclic compound
granted A61KA61K31/4184A61K31/519
Quick answer
US patent 10919891 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/4184, A61K31/519, A61P, A61P11/00